BindingDB logo
myBDB logout

11 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27744182 16 Rapid preparation of (3R,4S,5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease.EBI National Cheng-Kung University
27474919 10 Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency.EBI National Cheng-Kung University
26838810 16 Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerful▀-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomal▀-galactosidase.EBI Graz University of Technology
15771446 42 Biological properties of D- and L-1-deoxyazasugars.EBI Toyama Medical and Pharmaceutical University
9651160 52 Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases.EBI Hokuriku University
20457528 22 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.EBI University of Toyama
 37 Synthesis of a new inhibitor of α-fucosidaseEBI TBA
 5 Synthesis of C2-symmetrical polyhydroxyazepanes as inhibitors of glycosidasesEBI TBA
14684301 3 Novel O-glycosyl amino acid mimetics as building blocks for O-glycopeptides act as inhibitors of galactosidases.EBI University of Hamburg
10021944 8 Specific, uncompetitive inhibition of beta-galactosidases by a 5,6-isopropylidenedioxyfuro[2,3-d]isoxazole-3-methanol derivative.EBI Institut de chimie organique de l'Université de Lausanne